¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Permissions Requests - Help - - Sign up - Phone number 902 888 740

Indexed in:

Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES


  • SCImago Journal Rank (SJR):0,195
  • Source Normalized Impact per Paper (SNIP):0,103
Clin Invest Arterioscl 2002;14:295-6 - DOI: 10.1016/S0214-9168(02)78878-5
Tratamientos combinados en la arteriosclerosis. ¿Qué beneficios aportan?
J.M. Mostaza, , C. Lahoz
Unidad de Arteriosclerosis. Hospital Carlos III. Madrid. España
This article is only available in PDF
R. Collins,R. Peto,S. MacMahon,P. Hebert,N.H. Fiebach,K.A. Eberlein
Blood pressure, stroke and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context
Lancet, 335 (1990), pp. 827-838
L. Hansson
The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension
J Hypertens, 14 (1996), pp. 537-544
C.J. Vaughan,A.M. Gotto,C.T. Basson
The evolving role of statins in the management of atherosclerosis
J Am Coll Cardiol, 35 (2000), pp. 1-10
J.A. Staffa,J. Chang,L. Green
Cerivastatin and reports of fatal rhabdomyolysis
N Engl J Med, 346 (2002), pp. 539-540
H.R. Davis Jr.,K.K. Pula,K.B. Alton,R.E. Burrier,R.W. Watkins
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors in dogs
Metabolism, 50 (2001), pp. 1234-1241 http://dx.doi.org/10.1053/meta.2001.26737
D. Hunninghake,W. Insull Jr.,P. Toth,D. Davidson,J.M. Donovan,S.K. Burke
Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively
Atherosclerosis, 158 (2001), pp. 407-416
M.L. Kashyap,M.E. McGovern,K. Berra,J.R. Guyton,P.O. Kwiterovich,W.L. Harper
Long-term safety and efficacy of a once-daily niacin/ lovastatin formulation for patients with dyslipidemia
Am J Cardiol, 89 (2002), pp. 672-678
A. Faggiotto,R. Paoletti
State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action
Hypertension, 34 (1999), pp. 987-996
R.J. Gryglewski,W. Uracz,J. Swies,S. Chlopicki,E. Marcinkiewicz,M. Lomnicka
Comparison of endothelial pleiotropic actions of angiotensin converting enzyme inhibitors and statins
Ann N Y Acad Sci, 947 (2001), pp. 229-245
Correspondencia: Unidad de Arteriosclerosis. Hospital Carlos III. Sinesio Delgado, 10-12. 28029 Madrid. España (J.M. Mostaza jmostaza@hciii.insalud.es)
Copyright © 2002. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.